Tabla 4. Distribución de los pacientes hipertensos según control de su hipertensión.
Tabla 5. Distribución de los pacientes hipertensos según uso de tratamiento.
Tabla 6. Distribución de los grupos farmacológicos según prescripción médica en los pacientes hipertensos estudiados.
Leyenda: IECA: Inhibidores de la enzima convertidora de angiotensina.
Referencias bibliográficas
1. Balaguer Vintró I. Control y prevención de las enfermedades cardiovasculares en el mundo. Editorial. RevEsp Cardiol. 2004;57(6):487-94.
2. Kaplan NM. New European guidelines for the management of arterial hypertension: an American perspective. Pol Arch Med Wewn 2007;117(7):281-2.
3. García-Araujo M, Semprún-Fereira M, Sulbarán TA, Silva E, Calmón G, Campos G. Nutritional and metabolic factors as risk factors for cardiovascular diseases in an adult population in the city of Maracibo, Estado Zulia, Venezuela. Invest Clin 2001;42(1):23-42.
4. Sulbarán T, Silva E, Calmón G, Vegas A. Epidemiologic aspects of arterial hypertension in Maracaibo, Venezuela. J Hum Hypertens 2000;14 Suppl 1:S6-9.
5. Hernández-Hernández R, Armas-Padilla MC, Armas-Hernández MJ, Velasco M. The prevalence of hypertension and the state of cardiovascular health in Venezuela and surrounding nations. Ethn Dis 1998;8(3):398-405.
6. Hernández-Hernández R, Armas-Padilla MC, Armas-Hernández MJ, Velasco M. Hypertension and cardiovascular health in Venezuela and Latin American countries. Hum Hypertens 2000;14 (Suppl 1):S2-5.
7. Orellana K. (). Estudio Epidemiológico de la Hipertensión Arterial y otros Factores de Riesgos en el Estado Lara. Rev. FM MedVenezuela 1998; (3-4): 105-115.
8. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the: 29th WMA General Assembly, Tokyo, Japan, October 1975; 35th WMA General Assembly, Venice, Italy, October 1983; 41st WMA General Assembly, Hong Kong, September 1989; 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996; 52nd WMA General Assembly, Edinburgh, Scotland, October 2000; 53th WMA General Assembly, Washington 2002 (Note of Clarification on paragraph 29 added); 55th WMA General Assembly, Tokyo 2004 (Note of Clarification on Paragraph 30 added); 59th WMA General Assembly, Seoul, October 2008.
9. Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M. Prevalence and lifestyle characteristics of hypertensive patients with metabolic syndrome followed at an outpatient clinic in fukuoka, Japan. Hypertens Res 2007;30(11):1077-82.
10. Pedersen SA, Galatius S, Hecht Olsen M, Kuhn Madsen B, Kyst Madsen J, Nielsen OW. High Prevalence of Risk Factors in Coronary Artery Disease in EUROPA Gives HOPE for ACE Inhibitors after PEACE. Cardiology 2008;111(1):63-67.
11. Cuspidi C, Valerio C, Sala C, Esposito A, Masaidi M, Negri F, Zanchetti A, Mancia G. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure. Blood Press Monit 2008;13(1):7-13.
12. Oparil S. Women and hypertension: what did we learn from the Women's Health Initiative? Cardiol Rev 2006;14(6):267-75.
13. Ulmer H, Kelleher C, Diem G. Why eve is not adam: prospective follow-up in 149,650 women and men of colesterol and other risk. Factors related to cardiovascular and all-cause mortality. Journal of Women’s Health 2004;13(1):41-53.
14. Sarduy NM, Lugones BM: II Consenso Cubano de Climaterio y Menopausia. La Habana: Editorial CIMEQ; 2007.p.47.
15. Szczedrin von Hartman I. Manejo de la mujer con sobrepeso en la menopausia. Rev Iberoam Menop 2001:3(1):18-22.
16. Von Helde S, Cifuentes I, Palacios S. Influencia de la terapia hormonal de reemplazo en el peso y la distribución grasa corporal. Rev Iberoam Menop 2001;3(1):13-7.
17. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP.
Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2007;55(4):583-9.
18. Kuh D, Langenberg C, Hardy R, Kok H, Cooper R. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.BJOG 2005;112(4):476-85.
19. Laouani Kechrid C, Hmouda H, Ben Naceur MH, Ghannem H, Toumi S, Ajmi F. High blood presure for people aged more than 60 years in the distrct of Sousse. Tunis Med 2004;82(11):1001-5.
20. Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens (Greenwich) 2008;10(2):130-9.
21. Hertz RP, McDonald M, Unger AN, Lustik MB. Racial and ethnic disparities in the prevalence and management of cardiovascular risk factors in the United States workforce. J Occup Environ Med 2007;49(10):1165-75.
22. Oyama N, Gona P, Salton CJ, Chuang ML, Jhaveri RR, Blease SJ, Manning AR, Lahiri M, Botnar RM, Levy D, Larson MG, O'Donnell CJ, Manning WJ. Differential impact of age, sex, and hypertension on aortic atherosclerosis: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2008;28(1):155-9.
23. De Fronzo RA, Ferranini E. Insuline resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
24. Hanon O. Management of hypertension in the very elderly. Presse Med 2006;35(2):1047-53
25. Aronow WS..Drug therapy of older persons with hypertension. J Am Med Dir Assoc. 2006 Mar;7(3):193-6. Epub 2006.
26. Zaitune MP, Barros MB, César CL, Carandina L, Goldbaum M..Arterial hypertension in the elderly: prevalence, associated factors, and control practices in Campinas, São Paulo, Brazil] Cad Saude Publica. 2006 Feb;22(2):285-94. Epub 2006.
27. Cheung BM, Ong KL, Man YB, Lam KS, Lau CP. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich). 2006 Feb;8(2):93-8
28. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older u.s. Adults: data from the national health and nutrition examination survey 1988 to 2004. J Am Geriatr Soc 2007; 55(7):1056-65.
29. Ishine M, Okumiya K, Hirosaki M, Sakamoto R, Fujisawa M, Hotta N, Otsuka K, Nishinaga M, Doi Y, Matsubayashi K. Prevalence of hypertension and its awareness, treatment, and satisfactory control through treatment in elderly Japanese. J Am Geriatr Soc 2008;56(2):374-5.